Session Details
[Pe-054]English Poster Session 054 Neuroimmunology (Clinical study 3)
Sat. May 24, 2025 1:30 PM - 2:50 PM JST
Sat. May 24, 2025 4:30 AM - 5:50 AM UTC
Sat. May 24, 2025 4:30 AM - 5:50 AM UTC
ポスター会場(大阪国際会議場3F イベントホール)
Chairs: Hiroshi Kuroda（Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan）, Youwei Lin（Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry/ Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan）
[Pe-054-1]Methotrexate as the second line therapy for neurosarcoidosis
Hiroshi Kuroda1,2,3, Yoshiki Takai3, Kimihiko Kaneko3, Yuki Matsumoto3, Chihiro Namatame3, Toshiyuki Takahashi3, Tatsuro Misu3, Kazuo Fujihara1,2, Masashi Aoki3 (1.Department of Neurology, Southern TOHOKU Research Institute for Neuroscience Southern TOHOKU General Hospital, Japan, 2.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, Japan, 3.Department of Neurology, Tohoku University Graduate School of Medicine, Japan)
[Pe-054-2]The third nationwide survey of atopic myelitis and anti-plexin D1 antibody-related neuropathic pain
Jun-ichi Kira1,2,3, Xu Zhang2,4, Takayuki Fujii4, Mikio Mitsuishi2, Yumiko Uehara1, Miho Ushijima2, Sato Yoshidomi4, Ayako Sakoda1,2, Tomohiro Imamura2,3, Guzailiayi Maimaitijiang2, Satoshi Kuwabara5, Noriko Isobe4, Yuri Nakamura1,2,3 (1.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, International University of Health and Welfare, Japan, 2.Translational Neuroscience Research Center, Graduate School of Medicine, International University of Health and Welfare, Japan, 3.Department of Pharmaceutical Sciences, School of Pharmacy at Fukuoka, International University of Health and Welfare, Japan, 4.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 5.Department of Neurology, Graduate School of Medicine, Chiba University, Japan)
[Pe-054-3]Single center experience of immune effector cell-associated neurotoxicity syndrome (ICANS)
Kotaro Haruna1, Junko Ishii1, Daichi Imamura1, Yuya Nagai2, Ryusuke Yamamoto2, Daichi Kishi2, Haruki Shimada1, Kenta Tsutida1, Sota Uemura1, Ryosuke Oka1, Toshimiti Moriuchi1, Noriko Nomura1, Kazuma Ota1, Satoshi Hosoki1, Kota Maekawa1, Satoru Fujiwara1, Nobuyuki Ohara1, Hajime Yoshimura1, Nobuo Kohara1, Michi Kawamoto1 (1.Department of Neurology, Kobe City Medical Center General Hospital, Japan, 2.Department of Hematology, Kobe City Medical Center General Hospital, Japan)
[Pe-054-4]Efficacy of Rituximab in Steroid-Dependent Hypertrophic Pachymeningitis: A Case Series
Nathadon Sae-lao1, Jiraporn Jitprapaikulsan2,3 (1.Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand, 2.Siriraj Neuroimmunology Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand, 3.Division of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand)
[Pe-054-5]Tremor in Anti-NF155 Antibody-Positive Neuropathy patients
Hanna Okada, Yasunobu Hoshino, Kenji Suwa, Cossu Davide, Yuji Tomizawa, Nobutaka Hattori (Department of Neurology Juntendo University Faculty of Medicine, Japan)